Related by context. All words. (Click for frequent words.) 74 tumors 70 breast tumors 70 lung tumors 69 prostate tumors 68 metastatic tumors 68 cancers 67 endometrial cancers 67 prostate cancers 67 metastatic lesions 67 GISTs 67 breast cancers 67 pancreatic cancers 66 malignant tumors 66 colorectal tumors 66 malignancy 66 metastases 65 breast carcinomas 65 ovarian cancers 65 melanoma tumors 65 gliomas 65 renal cell carcinomas 65 malignant growths 65 bladder cancers 65 malignancies 64 metastatic cancer 64 colon tumors 64 medulloblastoma 64 atypical hyperplasia 64 ductal breast cancer 64 ovarian cancer 64 adenoma 64 precancers 64 pre cancerous growths 64 renal tumors 64 epithelial tumors 64 Tumours 64 pancreatic tumors 64 ovarian carcinoma 64 neurofibromas 64 lobular carcinoma 64 adenocarcinomas 64 colorectal carcinoma 64 pre cancerous lesions 64 hamartomas 64 PCa 63 synovial sarcoma 63 endostatin 63 carcinoid 63 precancerous lesions 63 ependymomas 63 prostate adenocarcinoma 63 malignant cells 63 lymphomas 63 neoplasia 63 CIN3 63 tumor 63 medulloblastomas 63 neuroendocrine tumors 63 benign tumors 63 seminomas 63 mammary tumors 63 neuroblastomas 63 cervical lesions 63 BRCA1 mutations 63 atherosclerotic lesions 62 prostate tumor 62 nestin 62 GBM tumors 62 epithelial ovarian cancer 62 precursor lesions 62 chromosomal abnormalities 62 Wilms tumor 62 bowel cancers 62 lung adenocarcinomas 62 glioblastoma 62 basal cell carcinomas 62 tumor cells 62 choriocarcinoma 62 grade gliomas 62 angiosarcoma 62 seminoma 62 pancreatic adenocarcinoma 62 ADPKD 62 neoplasms 62 B7 H3 62 neuroblastoma cells 62 serous ovarian cancer 62 glioblastoma tumors 62 invasive ductal 62 nonmelanoma skin cancers 62 melanomas 62 HPV infections 62 mammary cancers 61 breast lesions 61 tumor recurrence 61 leukaemias 61 grade cervical intraepithelial 61 teratoma 61 neoplasm 61 urothelial cancer 61 metastatic prostate cancer 61 metastatic melanomas 61 HGPIN 61 mucinous 61 neuroblastoma tumors 61 cell carcinomas 61 CIN2 + 61 malignant prostate 61 benign polyps 61 epithelial ovarian 61 precancerous cervical lesions 61 basal cell nevus syndrome 61 mosaicism 61 mesotheliomas 61 bladder tumors 61 Gliomas 61 peritoneal cancer 61 anaplastic 61 micrometastases 61 endocrine tumors 61 basal cell carcinoma BCC 61 gastric cancers 61 JMML 61 herpesviruses 61 carcinoma 61 HbF 61 pre cancerous polyps 61 pancreatic tumor 61 osteosarcomas 61 genetic abnormalities 61 advanced adenomas 61 GIST tumors 61 intestinal polyps 61 cervical carcinoma 61 malignant lymphoma 61 HER2 positive tumors 61 malignant lesions 61 neoplasias 61 cyclin E 60 papillomas 60 mutant protein 60 liposarcoma 60 ovarian tumor 60 occult metastases 60 squamous cell carcinoma SCC 60 thyroid cancers 60 untreated celiac disease 60 meningiomas 60 aneuploid cells 60 mesothelin 60 carcinomas 60 cervical intraepithelial neoplasia 60 endometrial cancer 60 testicular cancers 60 aneuploidies 60 colon cancers 60 p# mutations 60 molecular abnormalities 60 HPV# 60 EGFRvIII 60 fibroadenomas 60 Cholangiocarcinoma 60 lymph node metastases 60 neuroendocrine cancers 60 benign lesions 60 prostate cancer CaP 60 cisplatin resistant 60 grade dysplasia 60 DCIS 60 colorectal cancer CRC 60 breast carcinoma 60 hyperplastic 60 prostate pancreatic 60 BRCA mutations 60 teratomas 60 ductal cancer 60 HER2 receptor 60 IgA antibodies 60 premalignant lesions 60 lesions 60 abnormal growths 60 precancerous condition 60 noncancerous cells 60 glioblastomas 60 invasive carcinoma 60 Tumors 60 curable cancers 60 astrocytomas 60 MYCN amplification 59 ependymoma 59 advanced adenoma 59 incidentalomas 59 colorectal cancers 59 leukemic cells 59 PARP inhibitor 59 p# mutation 59 hepatocellular carcinomas 59 malignant neoplasm 59 peritoneal carcinomatosis 59 myeloma cells 59 CMV infection 59 cancerous tumors 59 malignant pleural mesothelioma 59 EGFR mutations 59 familial ALS 59 cancerous growths 59 axillary lymph nodes 59 carcinoid tumor 59 pleural mesothelioma 59 operable breast cancer 59 leiomyomas 59 endometrial carcinoma 59 squamous cell carcinomas 59 PCNSL 59 ZNF# 59 pre malignant lesions 59 CIN2 59 mtDNA mutations 59 brain tumors 59 gastrointestinal cancers 59 adenocarcinoma 59 lung nodules 59 cancerous cells 59 chlamydial infection 59 colorectal polyp 59 papillary 59 mammary cells 59 lobular breast cancer 59 prostate tissue 59 lung cancers 59 Li Fraumeni 59 squamous cell cancers 59 bone metastasis 59 nodal metastasis 59 pre cancerous cells 59 precancerous spots 59 BRCA2 mutations 59 PARP inhibition 59 germline mutations 59 gastric adenocarcinoma 59 distant metastases 59 HNSCC 59 uterine tumors 59 urothelial carcinoma 59 chromosomal rearrangement 59 leiomyosarcoma 59 sarcomatoid 59 somatic mutations 59 MGUS 59 glioma cells 59 HER2 positive cancers 59 granulocytes 59 Uterine fibroids 59 OGG1 59 histopathologic examination 59 oncoprotein 59 CLL cells 59 thyroid nodules 58 HER2 gene 58 prostate cancer PCa 58 cell carcinoma 58 neoplastic cells 58 BRCA mutation 58 HER2 amplification 58 mutated genes 58 basal cells 58 melanoma 58 vimentin 58 varicocele 58 adenomas 58 FGFR2 58 benign growths 58 TET2 58 grade glioma 58 colorectal neoplasms 58 pleomorphic 58 lobular cancer 58 paragangliomas 58 malignant transformation 58 cancerous polyps 58 Glioblastoma 58 Malignant tumors 58 BRCA1 gene 58 lobular carcinomas 58 pre cancerous lesion 58 basal cell cancers 58 neoplastic lesions 58 benign nodules 58 autoantibodies 58 NKX2 58 chromosomal anomalies 58 xenograft tumors 58 neuroblastoma tumor 58 situ LCIS 58 epithelial cancers 58 beta thalassemia 58 Melanomas 58 primitive neuroectodermal tumors 58 varicoceles 58 sporadic ALS 58 pituitary tumors 58 pre cancerous 58 TGFBR1 * 6A 58 uPAR 58 metastatic tumor 58 gastric carcinoma 58 EZH2 58 lymph node metastasis 58 invasive breast cancer 58 ERCC1 58 FGFR1 58 prostate carcinoma 58 schwannomas 58 carcinoid tumors 58 metastatic cancers 58 TAp# 58 invasive cervical cancer 58 choroidal melanoma 58 hypermethylation 58 leiomyoma 58 malignant melanoma 58 BRCA2 mutation 58 chromosomal aberrations 58 polycystic ovarian syndrome PCOS 58 sentinel nodes 58 metastatic prostate 58 gastrointestinal stromal tumor 58 CGG repeats 58 metastasis 58 WT1 58 metastatic lesion 58 EGFR mutation 58 pulmonary metastases 58 mutations 58 sarcomas 58 penetrance 58 HER-2/neu 58 Immunohistochemical analysis 58 AAT deficiency 58 K ras mutations 58 cysts 58 PrPSc 57 noncancerous tumors 57 Epstein Barr virus EBV 57 multidrug resistance 57 alveolar rhabdomyosarcoma 57 tumoral 57 liver metastases 57 BRCA deficient 57 sarcosine 57 polycystic ovary syndrome PCOS 57 thymosin 57 metastatic disease 57 squamous 57 MALT lymphoma 57 malignant pancreatic 57 prostate cancer CRPC 57 lung carcinomas 57 retinoblastoma 57 medulloblastoma tumors 57 colorectal polyps 57 PARP inhibitors 57 malignant melanomas 57 lymphatic tissue 57 low expressors 57 BRAF mutations 57 premalignant 57 hereditary breast cancer 57 hematopoietic cancers 57 MUC1 protein 57 ductal 57 neuroblastoma 57 paraganglioma 57 malaria parasite Plasmodium falciparum 57 gastrointestinal stromal tumors 57 chromosomal instability 57 cholangiocarcinoma 57 genetic abnormality 57 histologic subtype 57 luminal cells 57 malignant nodules 57 nasopharyngeal carcinoma 57 nanomolar 57 node metastases 57 leukaemic stem cells 57 sarcoma 57 NF2 57 oropharyngeal cancer 57 egg follicles 57 gene amplification 57 PTLD 57 desmoid tumor 57 skeletal metastases 57 precancerous growths 57 systemic scleroderma 57 rhabdomyosarcoma 57 chromosome aberrations 57 cutaneous melanoma 57 cancerdefine 57 endometrial 57 differentiated thyroid 57 APOL1 57 spontaneous mutations 57 leukemia ALL 57 cancerous lesions 57 liver metastasis 57 NF1 57 pCR 57 melanocytic nevi 57 papillary carcinoma 57 fibroadenoma 57 CMV disease 57 aneuploidy 57 immunocompetent 57 ovulatory cycles 57 neoplastic 57 breast cancer metastasis 57 leukemia AML 57 uveal melanoma 57 lung adenocarcinoma 57 astrocytoma 57 polyps 57 DCIS lesions 57 Carcinoid tumors 57 Hurthle cell 57 gene rearrangements 57 distant metastasis 57 uterine cancers 57 epithelial tissues 57 Adenomas 57 genetic mutations 57 Glioblastomas 57 testicular germ cell 57 genes BRCA1 57 BRCA1 mutation 57 KRAS mutations 57 papillary thyroid cancer 57 EGFR gene 57 chitinase 57 oncogenic HPV types 57 ductal carcinomas 57 B Cell Lymphoma 57 hamartoma 57 malignant tissue 57 vulvar intraepithelial neoplasia 57 lipomas 57 c MYC 57 pituitary adenomas 57 chromosome abnormality 57 herpes infection 57 chemoresistance 57 STAT3 57 Testicular cancer 57 PTPN# 56 varices 56 poorer prognosis 56 embryonal rhabdomyosarcoma 56 intestinal metaplasia 56 CIN3 + 56 precancerous cervical 56 transitional cell carcinoma 56 thyroglobulin 56 colorectal adenocarcinoma 56 hepatocellular carcinoma HCC 56 esophageal cancers 56 Polyps 56 granulosa cell 56 malignant ovarian 56 amyloid deposits 56 precancerous 56 ALCL 56 mTOR inhibitors 56 neuro endocrine tumors 56 carcinoid cancer 56 Basal cell 56 elevated CRP 56 recurrent miscarriages 56 proto oncogene 56 myeloproliferative diseases 56 lung metastases 56 benign breast 56 EBV infection 56 trophoblast cells 56 mesenchymal cells 56 malformation 56 EGF receptor 56 micrometastasis 56 nonsense mutations 56 GSTT1 56 ASCUS 56 endometrial hyperplasia 56 transgenic rats 56 anal lesions 56 BRCA2 56 pDCs 56 metastatic lymph nodes 56 hTERT 56 gynecologic malignancy 56 renal carcinoma 56 overexpress 56 pre eclampsia 56 Candida infection 56 precancer 56 rectal cancers 56 castrated mice 56 gene mutations 56 HER2 positive breast cancer 56 aromatase 56 progesterone receptor negative 56 suppressor gene 56 MDM2 56 atypia 56 gynecological cancers 56 Fas ligand 56 pheochromocytoma 56 HER2 expression 56 tumor suppressor protein 56 lymphocytic 56 EUS FNA 56 IGFBP 3 56 Cysts 56 androgen receptor AR 56 histological subtype 56 MSMB 56 oligodendroglioma 56 lobules 56 cancerous breast 56 ovarian malignancy 56 PGDH 56 Wwox 56 atypical ductal hyperplasia 56 abnormal chromosomes 56 colorectal cancer 56 nodular melanoma 56 mutated gene 56 acute promyelocytic leukemia 56 FMR1 gene 56 beta1 integrin 56 Akt1 56 lung metastasis 56 TTR gene 56 premenopausal breast cancer 56 Rectal cancer 56 Leydig cell 56 esophageal squamous cell carcinoma 56 keloids 56 benign moles 56 Li Fraumeni syndrome 56 Peutz Jeghers syndrome 56 HGPS 56 inherited mutations 56 precancerous polyps 56 colorectal tumor 56 C#Y 56 abnormal proteins 56 premature menopause 56 BRAF mutation 56 endometrioid 56 Metastases 56 castrate resistant 56 urethritis 56 DHFR 56 recurrent ovarian cancer 56 glioblastoma multiforme 56 GNAQ 56 chromosomal defect 56 hedgehog pathway 56 PDGFRA 56 mesothelial cells 56 Gleevec resistant 56 medullary thyroid cancer 56 locoregional recurrence 56 precancerous polyp 56 sentinel lymph nodes 56 neutralizing antibody 56 estrogen receptor negative 56 adenomatous polyp 56 polyps growths 56 G6PD 56 colorectal gastric 56 androgen deprivation 56 glioblastoma cells 56 NQO1 56 M. genitalium 56 mutant proteins 56 spontaneously regress 56 CMV infections 56 GRNOPC1 cells 56 basal cell carcinoma 56 basal cell 56 recurrent glioblastoma 55 breast cancer 55 ABCB1 55 genital tract infections 55 systemic lupus erythematosus SLE 55 abnormal cytology 55 solid tumors 55 IUGR 55 crystallin 55 squamous cell lung cancer 55 Papillary 55 EGFR mutant 55 PKM2 55 metastatic 55 transfusion syndrome 55 cervical lymph nodes 55 noncancerous prostate 55 testicular tumors 55 mitochondrial mutations 55 MLL gene 55 tumor suppressor gene 55 oligodendrogliomas 55 lymph node involvement 55 breast endometrial 55 EGFR receptor 55 Metastatic 55 tumor metastases 55 metastatic neuroendocrine tumors 55 primary biliary cirrhosis 55 miRs 55 superficial bladder cancer 55 vaginal cancers 55 vestibular schwannomas 55 LRAT 55 granzyme B 55 mutant p# 55 olaparib 55 TIMP 55 protein fragment 55 alkylating agents 55 orchitis 55 Anaplastic 55 PTEN gene 55 metastatic gastric 55 narcolepsy cataplexy 55 IDH1 55 nonmelanoma skin cancer 55 HER2 positive 55 fibroblast cells 55 interferon pathway 55 adenomatous polyps 55 ocular melanoma 55 lymphoid organs 55 BCR ABL 55 GPNMB 55 pneumococci 55 eosinophilic 55 chromosomal alterations 55 IgG antibodies 55 pyloric stenosis 55 excitatory synapses 55 NNRTI resistance 55 myocytes 55 S. maltophilia 55 Cancerous cells 55 organophosphate exposure 55 ARVD 55 HNPCC 55 stromal cells 55 Circulating tumor cells 55 somatostatin receptors 55 abnormalities 55 hydronephrosis 55 TGF alpha 55 melanoma lesions 55 genetic defect 55 chemo resistant 55 supratentorial 55 carbohydrate antigens 55 undifferentiated stem cells 55 contralateral breast 55 dysplastic lesions 55 glandular tissue 55 primary cilia 55 immunohistochemical staining 55 bacterial vaginosis 55 lymph node biopsies 55 HER2 overexpression 55 relapsed ovarian cancer 55 invasive ductal carcinoma 55 BRAF V#E 55 myeloproliferative disorders 55 TEL AML1 55 invasive ductal carcinomas 55 hemangiomas 55 HCV infections 55 BRCA mutation carriers 55 chronic granulomatous disease 55 haematopoietic 55 tumor suppressor genes 55 chemoresistant 55 miR #b [001] 55 Hurler syndrome 55 cystic lesions 55 beta catenin protein 55 HMGA2 55 pathogenic mutations 55 lymph nodes 55 MMP inhibitors 55 germline mutation 55 ALK mutations 55 FLT3 55 urothelial bladder cancer 55 situ CIS 55 cervical vaginal 55 abnormal cervical 55 anal cancers 55 PTEN mutations 55 oral squamous cell 55 micronuclei 55 MCAD deficiency 55 mutated BRCA1 55 Glioblastoma multiforme 55 GBV C 55 E selectin 55 pulmonary metastasis 55 GBMs 55 fallopian tube carcinoma 55 herpes viruses 55 keloid 55 genetic variants associated 55 BMPR2 55 PTEN protein 55 transgenic mice 55 granulomas 55 recurrent miscarriage 55 prostate specific 55 mutated K ras 55 ductal adenocarcinoma 55 syngeneic 55 AAV2 55 Colon polyps 55 HER2 protein 55 brain lesions 55 histologies 55 RAS mutations 55 activin 55 lymphoid cells 55 malignant gliomas 55 invasive lobular 55 genetic alteration 55 cervical neoplasia 55 lysosomal storage diseases 55 ovarian follicles 55 ErbB2 55 liver scarring 55 GPC5 55 prostate cancer 55 neuronal stem cells 55 mutation 55 monozygotic twins 55 VEGF receptor 55 Wegener granulomatosis 55 miRNA genes 55 epithelial cell 55 papillary thyroid carcinoma 55 Nodules 55 Bcl xL 55 transgene expression 55 pelvic lymph nodes 55 polypoid 55 glioma tumors 55 biochemical relapse 55 squamous cells 55 brain tumor glioblastoma multiforme 55 heterozygotes 55 ovules 55 pancreatic carcinoma 55 cardiac fibroblasts 55 caveolin 1 55 chlamydial 55 biopsy specimen 55 BCL#A 55 neuropilin 55 parathyroid carcinoma 55 somatic mutation 55 Kaposi sarcoma 55 skin cancers 55 mRNA transcripts 55 lymphoblastic leukemia 55 cancer 55 cell lymphomas 55 Endometrial cancer 55 TH# cells 55 Hashimoto thyroiditis 55 ectoderm 55 NF kB pathway 55 IDH1 mutation 55 T1a 55 CagA 55 dysplastic 55 primordial germ cells 55 stem progenitor cells 55 suppressor cells 55 squamous carcinoma 55 familial pancreatic cancer 54 precancerous tumors 54 p#NTR 54 TGF β 54 SPINK1 54 hypermethylated 54 Her2 54 premalignant lesion 54 neurofibroma 54 acute lymphoid leukemia 54 adenomatous 54 IDH1 mutations 54 HAAH 54 postmenopausal breast cancer 54 anti apoptotic proteins 54 malignant ascites 54 pancreatic lung 54 MSH2 54 thoracic aortic disease 54 holoprosencephaly 54 immunoreactivity 54 MAGE A3 54 LRP5 54 epithelioid 54 atherosclerotic plaques 54 cytogenetic responses 54 BRCA2 mutation carriers 54 prognostic indicator 54 germline stem cells 54 infarcts 54 biochemical recurrence 54 diagnostic biomarker 54 cancerous lumps 54 Candida infections 54 bone marrow stem cells 54 flavopiridol 54 cranial radiation 54 MetAP2 54 Helicobacter pylori H. pylori 54 trophoblasts 54 EGFR protein 54 Clusterin 54 #.#ng/ml 54 genetic alterations 54 tumor xenografts 54 precancerous cells 54 methylation markers 54 LHRH receptor positive 54 neutralizing antibodies 54 Inhibin B 54 A. fumigatus 54 germ cells 54 BRCA1 mutation carriers 54 embryonal 54 malignant polyps 54 endometriosis 54 LRP6 54 Squamous cell carcinomas 54 pancreatic islet 54 intraepithelial 54 Glioma 54 chimerism 54 mutated BRAF gene 54 hematological diseases 54 TNFa 54 cancerous tissue 54 E cadherin 54 lymphoid tissue 54 pT2 54 carcinoembryonic antigen 54 breast cancer subtypes 54 Malignant Melanoma 54 germline 54 BRAF gene 54 colorectal carcinomas 54 EGFR inhibitors 54 renal cell carcinoma 54 transplanted bone marrow 54 metastatic bladder 54 immunized mice 54 breast tissue 54 IGF1R 54 vaginal lesions 54 IGFBP 54 soft tissue sarcomas 54 KRAS oncogene 54 trans retinoic acid ATRA 54 Foxp3 54 SHBG levels 54 PC# cells 54 kidney cysts 54 iNOS 54 Neural stem cells 54 VUR 54 thyrotropin 54 synuclein 54 pDC 54 genital herpes infections 54 lymphoid 54 gastrointestinal stromal tumors GIST 54 malignant fibrous histiocytoma 54 bronchial epithelial cells 54 HDAC6 54 ovarian hormones 54 osteosarcoma 54 goblet cells 54 colon polyps 54 pT3 54 acute leukemias 54 pneumocystis 54 CDK4 54 aneuploid 54 NKT cells 54 follicular lymphomas 54 tumor shrinkage 54 precancerous lesion 54 herpes simplex encephalitis 54 DFMO 54 interleukins 54 p#INK#a 54 GSTP1 54 NF1 gene 54 amyloid plaque 54 tenascin C 54 troponin T 54 ccRCC 54 IGF 1R 54 pheochromocytomas 54 VHL gene 54 HER2 + 54 specific antigen 54 cardiac progenitor cells 54 PDGFR 54 HPV subtypes 54 K#R [002] 54 Hirschsprung disease 54 dystrophy 54 nodal metastases 54 phosphate S1P 54 antibodies 54 unresectable tumors 54 K ras gene 54 hepatic fibrosis 54 tumor biopsies 54 molecular subtypes 54 anterior uveitis 54 periodontitis 54 PIK3CA 54 LRRK2 gene 54 metastatic malignant melanoma 54 endometrial tumors 54 breast lumps 54 gastrointestinal stromal tumors GISTs 54 MIF protein 54 estrogen receptor ER 54 huntingtin gene 54 missense mutations 54 grade cervical dysplasia 54 bowel polyps 54 irradiated mice 54 C1q 54 IDH2 54 thymoma 54 gene expression profiles 54 breast cancer genes BRCA1 54 papillary RCC 54 Carcinoma 54 lymphoproliferative disorders 54 allogeneic transplants 54 neuroendocrine carcinoma 54 Candida species 54 malignant lymphomas 54 blastomeres 54 homodimers 54 chemopreventive 54 GRP# 54 microfilariae 54 lymphoblastic lymphoma 54 graft dysfunction 54 abnormal prions 54 ptau 54 HCV infection 54 cytoreduction 54 HPV types 54 myeloid leukemia 54 ectopic 54 fetal malformations 54 HCMV 54 oesophageal adenocarcinoma 54 pelvic malignancies 54 Cryptococcus neoformans 54 de novo mutations 54 TP# mutation 54 thymic carcinoma 54 dysplasia 54 advanced neoplasia 54 fibrous tangles 54 cultured neurons 54 ovarian hyperstimulation syndrome 54 chemopreventive agent 54 hormone gastrin 54 C EBP alpha 54 NPY expression 54 sCJD